Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy

Figure 3

Association between PDL2 expression and immune-related signatures in the ICI cohorts. (a) Heat map of Padmanee IFN-γ signature genes in ICI-treated cohorts. (b–f) The ssGSEA score of immune cell signatures comparing between the PDL2-high group and the PDL2-low group in the ICI-treated cohorts. Wilcoxon’s test was used to compare the differences.

(a)

(b)

(c)

(d)

(e)

(f)